Combining Diagnostics and Artificial Intelligence enabling Precision Medicine, Risk Prediction and Prognosis to Guide Therapy.
How it work
NASH Patient
If diagnosed, you may be at an early stage or late stage of liver disease. Here is how our products helps you to examine the disease.
COVID Patient
LIVERFASt™ can safely provide the complete liver assessment clinically needed, whether a COVID-19 patient has pre-existing conditions such as hepatitis B or C, NASH or Fatty Liver or even those with undiagnosed liver disease.
